Cann American Corp. is a development stage company dedicated to advancing healthcare solutions through innovative therapies. The company focuses on making healthcare affordable and accessible. By leveraging cutting-edge technology, the company aims to reduce costs and improve the availability of high-quality healthcare services for all patients. The company was formerly known as Canamed4Pets, Inc....
Cann American reported revenue of $0 for fiscal year 2012, and net income of -$1.65 million. In Q2 2013 (the quarter ended August 31, 2012) revenue was $0. Its market capitalization was $1.15 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended February 29, 2012; market data as of October 8, 2026.
No profile data available.